SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-20-142919
Filing Date
2020-05-14
Accepted
2020-05-14 17:09:11
Documents
15

Document Format Files

Seq Description Document Type Size
1 S-1/A d844461ds1a.htm S-1/A 1032183
2 EX-23.1 d844461dex231.htm EX-23.1 1969
3 GRAPHIC g844461g03a56.jpg GRAPHIC 100285
4 GRAPHIC g844461g04l43.jpg GRAPHIC 64409
5 GRAPHIC g844461g18k19.jpg GRAPHIC 89959
6 GRAPHIC g844461g19r33.jpg GRAPHIC 109219
7 GRAPHIC g844461g31f25.jpg GRAPHIC 101535
8 GRAPHIC g844461g35o24.jpg GRAPHIC 87211
9 GRAPHIC g844461g41c81.jpg GRAPHIC 62667
10 GRAPHIC g844461g50a29.jpg GRAPHIC 55614
11 GRAPHIC g844461g50b68.jpg GRAPHIC 72645
12 GRAPHIC g844461g62y21.jpg GRAPHIC 65280
13 GRAPHIC g844461g63v50.jpg GRAPHIC 70875
14 GRAPHIC g844461g64b64.jpg GRAPHIC 100708
15 GRAPHIC g844461g71p99.jpg GRAPHIC 50472
  Complete submission text file 0001193125-20-142919.txt   2449411
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-238194 | Film No.: 20878846
SIC: 2836 Biological Products, (No Diagnostic Substances)